International Journal Of Applied Medical Sciences And Research • pp. 1-12
PRECISION MEDICINE AND PHARMACOGENOMICS: TRANSFORMING PERSONALIZED TREATMENT AND CLINICAL DECISION-MAKING
Abstract
Precision medicine has emerged as an important development in modern healthcare, focusing on the customization
of medical treatment according to individual genetic, biological, environmental, and lifestyle characteristics. Unlike
traditional medical approaches that generally apply similar treatment strategies to large patient populations,
precision medicine recognizes that individuals may respond differently to the same disease treatment or medication.
Pharmacogenomics, an essential component of precision medicine, examines how genetic variations influence drug
metabolism, effectiveness, and the risk of adverse drug reactions. By incorporating genetic information into clinical
decisions, healthcare professionals can make more informed choices regarding medication selection, dosage, and
treatment planning. This research examines the role of precision medicine and pharmacogenomics in transforming
personalized treatment and clinical decision-making. It explores their applications in cardiovascular diseases,
cancer treatment, mental health, infectious diseases, and chronic conditions. The study also investigates challenges
associated with genetic testing, healthcare costs, data privacy, professional training, and unequal access to genomic
technologies. A qualitative descriptive methodology is adopted through the analysis of existing scientific literature
and clinical guidelines. The findings indicate that pharmacogenomic information can support safer medication use
and improve treatment selection when reliable evidence connects specific genetic variations with particular
medicines. However, genetic information must be interpreted alongside other clinical factors, including age, kidney
and liver function, medical history, and drug interactions. The research concludes that precision medicine can
strengthen healthcare decision-making through evidence-based personalized treatment, but its successful
implementation requires accessible genetic testing, updated clinical guidelines, trained professionals, ethical data
management, and equitable healthcare policies.
Record
- Identifier
- https://doi-services.com/1167/312
- Published
- 2026-11-16
- Version
- 1